FDA’s Center for Drug Evaluation and Research (CDER) approved a wide range of therapies in 2023 that will help patients and consumers live better and possibly longer lives.
The Institute for Safe Medication Practices, which is focused on preventing medication errors, added 82 new drug pairs to its list of medicines requiring special safeguards to reduce error risk.